Brainstorm Cell Therapeutics Inc.
BCLI· OTC
Filed Mar 27, 2014 · 10-K · 86 days after period end · 0001144204-14-018114
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$1.22M | -$2.24M | -$5.00M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 27, 2014 · 86 d after period end